Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 21, 2025NANO

Dual-Regulated Nanodrug Potentiates Immunotherapy by Synergizing Ferroptosis with Radiotherapy to Reverse the Immunosuppressive Tumor Microenvironment

View Full Paper
Ask AI
Bookmark
Share

Authors

WZWeiheng ZhangALAnwen Liu

Discussion

Loading...

Member takes

Overview

Dual-regulated nanodrug improves immunogenic cell death and T-cell infiltration in cold tumors, suggesting a new treatment strategy.

Key Points

  • To investigate a nanodrug that synergizes ferroptosis with radiotherapy to enhance immunotherapy in cold tumors.
  • Developed an iron-based metal-organic framework loaded with disulfiram.
  • Examined effects of the nanodrug on ferroptosis induction and immunogenic cell death.
  • Conducted in vivo studies using a 4T1 breast carcinoma model.
  • Significant tumor suppression observed in the 4T1 model.
  • Increased CD8+ T cell infiltration and dendritic cell maturation recorded.
  • Induction of abscopal effects which point to a systemic anti-tumor immune response.

Cite This Study

Zhang et al. (2025) studied this question.

synapsesocial.com/papers/6924e3e6c0ce034ddc34eb52https://doi.org/10.1142/s1793292026500426
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Synergistic Ferroptosis–Immunotherapy Nanoplatforms: Multidimensional Engineering for Tumor Microenvironment Remodeling and Therapeutic Optimization2025 · 29 citations
  2. 2An inflammation-modulating ferroptotic nanoplatform for immune-compatible cancer therapy2026
  3. 3Induced Ferroptosis Pathway by Regulating Cellular Lipid Peroxidation With Peroxynitrite Generator for Reversing “Cold” Tumors2024 · 6 citations
  4. 4Fe/Al‐LDH Nanomedicine for Antitumor Ferroptosis‐Immunotherapy by Immunosuppression Reversal2024 · 48 citations
  5. 5Reengineering immunotherapeutic responses: ferroptosis-primed radiotherapy converts cold-colorectal tumors into immunotherapy checkpoint inhibitor-sensitive hot lesions2026 · 3 citations